Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5277333
Max Phase: Preclinical
Molecular Formula: C45H44ClN9O6S
Molecular Weight: 874.42
Associated Items:
ID: ALA5277333
Max Phase: Preclinical
Molecular Formula: C45H44ClN9O6S
Molecular Weight: 874.42
Associated Items:
Canonical SMILES: Cc1sc2c(c1C)C(c1ccc(Cl)cc1)=N[C@@H](CC(=O)NCCCCC(=O)NCc1ccc(CNc3cccc4c3C(=O)N(C3CCC(=O)NC3=O)C4=O)cc1)c1nnc(C)n1-2
Standard InChI: InChI=1S/C45H44ClN9O6S/c1-24-25(2)62-45-38(24)40(29-14-16-30(46)17-15-29)50-33(41-53-52-26(3)54(41)45)21-37(58)47-20-5-4-9-35(56)49-23-28-12-10-27(11-13-28)22-48-32-8-6-7-31-39(32)44(61)55(43(31)60)34-18-19-36(57)51-42(34)59/h6-8,10-17,33-34,48H,4-5,9,18-23H2,1-3H3,(H,47,58)(H,49,56)(H,51,57,59)/t33-,34?/m0/s1
Standard InChI Key: VGJRFTAYDQAQDX-CDRRMRQFSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 874.42 | Molecular Weight (Monoisotopic): 873.2824 | AlogP: 5.81 | #Rotatable Bonds: 14 |
Polar Surface Area: 196.85 | Molecular Species: NEUTRAL | HBA: 12 | HBD: 4 |
#RO5 Violations: 3 | HBA (Lipinski): 15 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.59 | CX Basic pKa: 4.35 | CX LogP: 4.95 | CX LogD: 4.95 |
Aromatic Rings: 5 | Heavy Atoms: 62 | QED Weighted: 0.08 | Np Likeness Score: -0.91 |
1. Ding M, Shao Y, Sun D, Meng S, Zang Y, Zhou Y, Li J, Lu W, Zhu S.. (2023) Design, synthesis, and biological evaluation of BRD4 degraders., 78 [PMID:36563515] [10.1016/j.bmc.2022.117134] |
Source(1):